+12052497424
info@rareai.org
Chief Executive Officer, Dr. Lurong Pan
Dr Pan has over 15 years of computational biology and computational drug design experiences in small molecule, protein and RNA medicine. Dr. Pan hold a PhD in computational chemistry from the University of Alabama at Birmingham, a master’s in AI computer science from Georgia Tech. Dr. Pan was a Senior Scientist at University of Alabama at Birmingham Medical School and was previously a Senior Investigator at Global Health Drug Discovery Institute, a non-profit research institute founded by the Bill & Melinda Gates Foundation. She has built an AI drug discovery platform integrated billions of pharmacology data and applied to global health drug discovery research tackling diseases impacting the developing world. She also received the Pandemic Preparedness Award from Merck in 2020.
Chief Scientific Officer, Dr. Kyle Brewer
Dr. Brewer is a scientist with expertise in molecular biophysics, regenerative medicine, and AI-driven drug development. He serves as Associate Director of Advanced Drug Delivery and Regenerative Biomaterials at Stanford University. His prior roles include co-founding ETTA Biotechnology to develop AI-designed small molecules, contributing to biological model tuning at OpenAI, and advancing mRNA therapies at Rejuvenation Technologies. Dr. Brewer earned his Ph.D. in Molecular Biophysics from UT Southwestern and holds dual degrees in Biochemistry and Chemistry from North Carolina State University.